Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice

Introduction. Studied patients with oesophageal cancer do not represent normal daily presentation. Aim. A retrospective study was done in all consecutive patients in order to describe presentation, treatment, and survival. Patients. All patients in a ten-year period were included. Patients were grou...

Full description

Saved in:
Bibliographic Details
Published in:ISRN Gastroenterology Vol. 2013; pp. 205417 - 5
Main Authors: Loffeld, R. J. L. F., Dekkers, P. E. P.
Format: Journal Article
Language:English
Published: Egypt Hindawi Publishing Corporation 2013
Hindawi Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Introduction. Studied patients with oesophageal cancer do not represent normal daily presentation. Aim. A retrospective study was done in all consecutive patients in order to describe presentation, treatment, and survival. Patients. All patients in a ten-year period were included. Patients were grouped in three groups. Group 1: no metastases and potentially curable, dead, or alive at time of evaluation. Group 2: patients presenting with metastases and treated with palliative chemotherapy, and group 3: patients with or without metastases but untreatable because of low Karnofsky index or important comorbidity rendering treatment not feasible. Results. One hundred thirty one evaluable patients were included. There was no difference in histological type of the tumour. Patients in group 3 were significantly older. Survival was not different between groups 2 and 3. Survival in group 1 was significantly longer (P<0.0001) compared with groups 2 and 3. Patients in group 1 received treatment with chemoradiation and surgery. Patients in groups 2 and 3 were more often treated with palliative chemotherapy and endoscopic stenting. Conclusion. The overall survival of oesophageal cancer in normal daily life is poor. Supportive care seems to be the best treatment option in patients with metastases or low Karnofsky index. Palliative chemotherapy does not add to overall survival.
AbstractList Introduction. Studied patients with oesophageal cancer do not represent normal daily presentation. Aim. A retrospective study was done in all consecutive patients in order to describe presentation, treatment, and survival. Patients. All patients in a ten-year period were included. Patients were grouped in three groups. Group 1: no metastases and potentially curable, dead, or alive at time of evaluation. Group 2: patients presenting with metastases and treated with palliative chemotherapy, and group 3: patients with or without metastases but untreatable because of low Karnofsky index or important comorbidity rendering treatment not feasible. Results. One hundred thirty one evaluable patients were included. There was no difference in histological type of the tumour. Patients in group 3 were significantly older. Survival was not different between groups 2 and 3. Survival in group 1 was significantly longer ( P < 0.0001 ) compared with groups 2 and 3. Patients in group 1 received treatment with chemoradiation and surgery. Patients in groups 2 and 3 were more often treated with palliative chemotherapy and endoscopic stenting. Conclusion. The overall survival of oesophageal cancer in normal daily life is poor. Supportive care seems to be the best treatment option in patients with metastases or low Karnofsky index. Palliative chemotherapy does not add to overall survival.
Introduction . Studied patients with oesophageal cancer do not represent normal daily presentation. Aim . A retrospective study was done in all consecutive patients in order to describe presentation, treatment, and survival. Patients . All patients in a ten-year period were included. Patients were grouped in three groups. Group 1: no metastases and potentially curable, dead, or alive at time of evaluation. Group 2: patients presenting with metastases and treated with palliative chemotherapy, and group 3: patients with or without metastases but untreatable because of low Karnofsky index or important comorbidity rendering treatment not feasible. Results . One hundred thirty one evaluable patients were included. There was no difference in histological type of the tumour. Patients in group 3 were significantly older. Survival was not different between groups 2 and 3. Survival in group 1 was significantly longer () compared with groups 2 and 3. Patients in group 1 received treatment with chemoradiation and surgery. Patients in groups 2 and 3 were more often treated with palliative chemotherapy and endoscopic stenting. Conclusion . The overall survival of oesophageal cancer in normal daily life is poor. Supportive care seems to be the best treatment option in patients with metastases or low Karnofsky index. Palliative chemotherapy does not add to overall survival.
Introduction . Studied patients with oesophageal cancer do not represent normal daily presentation. Aim . A retrospective study was done in all consecutive patients in order to describe presentation, treatment, and survival. Patients . All patients in a ten-year period were included. Patients were grouped in three groups. Group 1: no metastases and potentially curable, dead, or alive at time of evaluation. Group 2: patients presenting with metastases and treated with palliative chemotherapy, and group 3: patients with or without metastases but untreatable because of low Karnofsky index or important comorbidity rendering treatment not feasible. Results . One hundred thirty one evaluable patients were included. There was no difference in histological type of the tumour. Patients in group 3 were significantly older. Survival was not different between groups 2 and 3. Survival in group 1 was significantly longer ( P < 0.0001) compared with groups 2 and 3. Patients in group 1 received treatment with chemoradiation and surgery. Patients in groups 2 and 3 were more often treated with palliative chemotherapy and endoscopic stenting. Conclusion . The overall survival of oesophageal cancer in normal daily life is poor. Supportive care seems to be the best treatment option in patients with metastases or low Karnofsky index. Palliative chemotherapy does not add to overall survival.
Author Dekkers, P. E. P.
Loffeld, R. J. L. F.
AuthorAffiliation Department of Internal Medicine and Gastroenterology, Zaans Medical Centre, P.O. BOX 210, 1500 EE Zaandam, The Netherlands
AuthorAffiliation_xml – name: Department of Internal Medicine and Gastroenterology, Zaans Medical Centre, P.O. BOX 210, 1500 EE Zaandam, The Netherlands
Author_xml – sequence: 1
  givenname: R. J. L. F.
  surname: Loffeld
  fullname: Loffeld, R. J. L. F.
  organization: Department of Internal Medicine and Gastroenterology Zaans Medical Centre P.O. BOX 210, 1500 EE Zaandam The Netherlands zaansmedischcentrum.nl
– sequence: 2
  givenname: P. E. P.
  surname: Dekkers
  fullname: Dekkers, P. E. P.
  organization: Department of Internal Medicine and Gastroenterology Zaans Medical Centre P.O. BOX 210, 1500 EE Zaandam The Netherlands zaansmedischcentrum.nl
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23710364$$D View this record in MEDLINE/PubMed
BookMark eNp9kctrVDEUxoO02Fq7ci8BN6JczfvhQihjX1Co2LoQhBBzz51JuZM7Jvda579vhmmLujCLk5ycH1--8D1DO2lIgNALSt5RKuV7RiivRQqqn6B9RixphCB05-HMrdlDh6XckLqEFdLYp2iPcU0JV2IffT_-vYIcIQXAt3Fc4Esow2rh5-B7PPP1On_AR_gaUvMNfMZXMc17wDNIYwZ8NU7tGn-Brocw1gn-5GO_xp-zr22A52i3832Bw_v9AH09Ob6enTUXl6fns6OLJjBjdWNaBkpYpqXWpuuYZ0FyYaDzhBtCNXSEgPVKKNGKNhhitPKaGusDGG8NP0Aft7qr6ccS2rAx53u3ynHp89oNPrq_Jyku3Hz45biSUilRBV7fC-Th5wRldMtYAvS9TzBMxVEuFbec0c1br_5Bb4Ypp_o9RwUzhGirVaXebqmQh1IydI9mKHGb4NwmOLcNrtIv__T_yD7EVIE3W2ARU-tv43_V7gC05p_L
CitedBy_id crossref_primary_10_2147_CMAR_S300672
crossref_primary_10_1111_1754_9485_13167
crossref_primary_10_1155_2024_7951391
crossref_primary_10_1007_s00520_020_05416_x
crossref_primary_10_1111_ans_14685
Cites_doi 10.3322/canjclin.55.2.74
10.1007/s11605-009-1109-y
10.1056/NEJMoa022343
10.3748/wjg.v16.i30.3793
10.1371/journal.pone.0014080
10.4065/mcp.2010.0421
10.1093/jnci/djn211
10.3748/wjg.15.5983
ContentType Journal Article
Copyright Copyright © 2013 R. J. L. F. Loffeld and P. E. P. Dekkers.
Copyright © 2013 R. J. L. F. Loffeld and P. E. P. Dekkers. R. J. L. F. Loffeld et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2013 R. J. L. F. Loffeld and P. E. P. Dekkers. 2013
Copyright_xml – notice: Copyright © 2013 R. J. L. F. Loffeld and P. E. P. Dekkers.
– notice: Copyright © 2013 R. J. L. F. Loffeld and P. E. P. Dekkers. R. J. L. F. Loffeld et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright © 2013 R. J. L. F. Loffeld and P. E. P. Dekkers. 2013
DBID RHU
RHW
RHX
NPM
AAYXX
CITATION
8FE
8FH
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1155/2013/205417
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing
PubMed
CrossRef
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
ProQuest Central Student
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest One Academic
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
CrossRef
PubMed


DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2090-4401
Editor Rishi, A. K.
Weimann, A.
Editor_xml – sequence: 1
  givenname: A. K.
  surname: Rishi
  fullname: Rishi, A. K.
– sequence: 2
  givenname: A.
  surname: Weimann
  fullname: Weimann, A.
EndPage 5
ExternalDocumentID 3055283011
10_1155_2013_205417
23710364
Genre Journal Article
GroupedDBID ---
4.4
53G
5VS
8FE
8FH
AAJEY
AAWTL
ABDBF
ACPRK
ADBBV
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BENPR
BHPHI
CCPQU
DIK
EAD
EAP
EAS
EBD
EBS
EJD
ESX
GROUPED_DOAJ
GX1
HCIFZ
HYE
IAO
IHR
KQ8
LK8
M7P
M~E
O5R
O5S
OK1
RHU
RHW
RHX
RPM
TUS
ITC
NPM
PGMZT
AAYXX
CITATION
AZQEC
DWQXO
GNUQQ
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c2897-8d2e649275778ff2a2c5348efa038017ef00e9a6464d4dc80876a7189ace8a983
IEDL.DBID RPM
ISSN 2090-4398
2090-4401
IngestDate Tue Sep 17 20:46:21 EDT 2024
Fri Aug 16 09:08:04 EDT 2024
Thu Oct 10 20:22:31 EDT 2024
Thu Nov 21 23:58:28 EST 2024
Sat Sep 28 08:09:53 EDT 2024
Sun Jun 02 18:46:58 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2897-8d2e649275778ff2a2c5348efa038017ef00e9a6464d4dc80876a7189ace8a983
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editors: A. K. Rishi and A. Weimann
ORCID 0000-0002-7149-850X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655664/
PMID 23710364
PQID 1428007976
PQPubID 686339
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3655664
proquest_miscellaneous_1356393218
proquest_journals_1428007976
crossref_primary_10_1155_2013_205417
pubmed_primary_23710364
hindawi_primary_10_1155_2013_205417
PublicationCentury 2000
PublicationDate 2013-00-00
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – year: 2013
  text: 2013-00-00
PublicationDecade 2010
PublicationPlace Egypt
PublicationPlace_xml – name: Egypt
– name: New York
PublicationTitle ISRN Gastroenterology
PublicationTitleAlternate ISRN Gastroenterol
PublicationYear 2013
Publisher Hindawi Publishing Corporation
Hindawi Limited
Publisher_xml – name: Hindawi Publishing Corporation
– name: Hindawi Limited
References (7) 2009; 15
(1) 2005; 55
(5) 2010; 16
(2) 2010; 14
(4) 2010; 85
(8) 2010; 5
(6) 2002; 347
(9) 2011; 30, article 94
(3) 2008; 100
20014464 - World J Gastroenterol. 2009 Dec 21;15(47):5983-91
21124934 - PLoS One. 2010 Nov 22;5(11):e14080
21970688 - J Exp Clin Cancer Res. 2011 Oct 05;30:94
15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
21123634 - Mayo Clin Proc. 2010 Dec;85(12):1080-9
18695138 - J Natl Cancer Inst. 2008 Aug 20;100(16):1184-7
20012379 - J Gastrointest Surg. 2010 Mar;14(3):476-83
20698042 - World J Gastroenterol. 2010 Aug 14;16(30):3793-803
12444180 - N Engl J Med. 2002 Nov 21;347(21):1662-9
2
3
4
5
6
7
8
References_xml – volume: 5
  issue: 11
  year: 2010
  ident: 8
  article-title: Esophageal cancer in young people: a case series of 109 cases and review of the literature
  publication-title:
– volume: 100
  start-page: 1184
  issue: 16
  year: 2008
  end-page: 1187
  ident: 3
  article-title: Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age
  publication-title:
– volume: 85
  start-page: 1080
  issue: 12
  year: 2010
  end-page: 1089
  ident: 4
  article-title: The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a Mayo cohort of 796 patients with extended follow-up after surgical resection
  publication-title:
– volume: 30, article 94
  year: 2011
  ident: 9
  article-title: Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
  publication-title:
– volume: 16
  start-page: 3793
  issue: 30
  year: 2010
  end-page: 3803
  ident: 5
  article-title: Neoadjuvant treatment of esophageal cancer
  publication-title:
– volume: 15
  start-page: 5983
  issue: 47
  year: 2009
  end-page: 5991
  ident: 7
  article-title: Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis
  publication-title:
– volume: 55
  start-page: 74
  issue: 2
  year: 2005
  end-page: 108
  ident: 1
  article-title: Global cancer statistics, 2002
  publication-title:
– volume: 347
  start-page: 1662
  issue: 21
  year: 2002
  end-page: 1669
  ident: 6
  article-title: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus
  publication-title:
– volume: 14
  start-page: 476
  issue: 3
  year: 2010
  end-page: 483
  ident: 2
  article-title: Delay in diagnostic workup and treatment of esophageal cancer
  publication-title:
– volume: 55
  start-page: 74
  issue: 2
  year: 2005
  ident: 1
  publication-title: Ca-A Cancer Journal for Clinicians
  doi: 10.3322/canjclin.55.2.74
– ident: 2
  doi: 10.1007/s11605-009-1109-y
– ident: 6
  doi: 10.1056/NEJMoa022343
– ident: 5
  doi: 10.3748/wjg.v16.i30.3793
– ident: 8
  doi: 10.1371/journal.pone.0014080
– ident: 4
  doi: 10.4065/mcp.2010.0421
– volume: 30, article 94
  year: 2011
  ident: 9
  publication-title: Journal of Experimental & Clinical Cancer Research
– ident: 3
  doi: 10.1093/jnci/djn211
– ident: 7
  doi: 10.3748/wjg.15.5983
SSID ssj0000494589
Score 1.870811
Snippet Introduction. Studied patients with oesophageal cancer do not represent normal daily presentation. Aim. A retrospective study was done in all consecutive...
Introduction . Studied patients with oesophageal cancer do not represent normal daily presentation. Aim . A retrospective study was done in all consecutive...
SourceID pubmedcentral
proquest
crossref
pubmed
hindawi
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 205417
SubjectTerms Cancer
Cancer therapies
Clinical Study
Comorbidity
Hospitals
Medical treatment
Mortality
Patients
Radiation therapy
Surgery
Survival analysis
Tumors
Title Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice
URI https://dx.doi.org/10.1155/2013/205417
https://www.ncbi.nlm.nih.gov/pubmed/23710364
https://www.proquest.com/docview/1428007976
https://search.proquest.com/docview/1356393218
https://pubmed.ncbi.nlm.nih.gov/PMC3655664
Volume 2013
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB6xSFS9IPoOj8pVuYaNX7HDDS0gLjxUqNRKlSKvMxZbLQEBK8S_Z5zHwlZVD73kYluJZsb5vrHnAbAdTDQci2llnE2Vki51BlUqvPQEzxkPWcx3Pjo3Jz_s_kEsk6P7XJgmaN-PJzv19Gqnnlw2sZU3V37Yx4kNz45HMtfEQtRwAAPihi9c9N8t5VW6aX0nsiJLCXBtl5dH0Em-Ppf00IrH9ntCEsDKXC2A0spl9IYfJn_jnH-GTr7AosM1WO1IJNtrP_YNLGH9Fl4dd9fk7-DXcwFjFg9a2SnGbgX066BVo6jn2122xy6wTn-SpbNzwq8psuakF1kMLXxk3zDEE30aYftuMn1kZ10-1Xv4fnhwMTpKuzYKqSdvijCoEpirQhhtjA1BOOG1VBaDyyThk8GQZVi4XOWqUpW3sUidI8gqnEfrCis_wHJ9XeMnYDqg5Bp5UZGXxbkf55KHcSW9Q2F4VSSw3cuxvGmrZZSNl6F1GSVftpJP4Gsn43_P2uzlX3Yb666MBeKI1hCJSuDLfJi2RLzncDVez2iO1MS7JJGXBD626pq_p9d4AmZBkfMJsdz24ghZYVN2u7O69f9euQGvRdNMIx7gbMLy_e0Mt2BwV80-Nyb8BJ068UM
link.rule.ids 230,315,729,782,786,887,4028,27932,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RIh4X3o9AASN6TdfP2OFWbVstolsqukggIUVeZ6Iu2qZVywr13zPOY-kixKGXXMZWFM9Mvm_s8QzAZmWj4ThMS-tdqrXyqbeoUxlUIHjmouLxvvPoyB58dTu7sUyO6e_CNEn7YTrbqucnW_XsuMmtPDsJgz5PbHA4HqrMEAvRgzW4Sf7K-ZUg_UdLerVpmt9JnvOUINd1N_MIPCnaF4oeRovYgE8qgliV6RVYunUc4-Ffs3-xzr-TJ6-g0d79a37HA7jX0U-23Yofwg2sH8HtcXfA_hi-_yl9zOIWLfuEsc8B_XRo1jBayPl7ts0mWKffyEfYESHfHFmzR4wsJiVess9YxbMAkrAdP5tfssPuJtYT-LK3OxmO0q4BQxooDiP0KiVmOpfWWOuqSnoZjNIOK89p2YXFinPMfaYzXeoyuFjezhPY5T6g87lTT2G9Pq3xOTBToRIGRV5SfCZEmGZKVNNSBY_SijJPYLNf_-KsrbNRNPGJMUXUWNFqLIF3nW7-P2qj11vRueRFEUvLESEi-pXA26WYnCmekPgaTxc0RhlibIpoTwLPWjUv39NbSgJ2xQCWA2Kh7lUJ6b0p2N3p-cW1Z76BO6PJeL_Y_3Dw8SXclU1LjrgNtAHrP88X-ArWLsrF68YNfgMB6wbd
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED6xISZexs9BYIARe80a_4oT3qZ21RBsVGxIICFFrn3Wirqs2lah_feck7SsCPEAL3mxoyj57vJ9Z5_vAHaCiYZTYOqNLVKlpE2tQZUKJx3Rc8ZDFs87Hxyboy_FYD-WyVm2-mqS9t14sltPz3bryWmTWzk7c71FnlhvdNiXuSYVonozH3prcJt8NhM3AvXvrfBVummAJ7IyS4l2i-50HhEoRfxc0kUrHpvwCUk0K3O1Qk13TmNM_GPyJ-X5ewLlDUYa3vuPd7kPm50MZXvtlAdwC-uHsHHYbbQ_gm-_SiCzuFTLPmLsd0A_H7qrHy3l4i3bYydYp1_JV9gxMeAUWbNWjCwmJ16zTxjingCNsIGdTK_ZqDuR9Rg-D_dP-gdp14ghdRSPEYt5gbkqhdHGFCEIK5yWqsBgM_r03GDIMixtrnLllXdFLHNnifRK67CwZSG3YL0-r_EpMB1Qco289BSnce7GueRh7KWzKAz3ZQI7CwyqWVtvo2riFK2riFrVopbAmw6fv8_aXmBXda55WcUScySMSIYl8Ho5TE4Vd0psjedzmiM1KTdJ8ieBJy3Uy-csrCUBs2IEywmxYPfqCGHfFO7usH72z3e-go3RYFh9eHf0_jncFU1njrgatA3rVxdzfAFrl37-svGEn2-GCV0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Experience+with+oesophageal+cancer%3A+a+ten-year+single+centre+study+reflecting+daily+practice&rft.jtitle=ISRN+Gastroenterology&rft.au=Loffeld%2C+R+J+L+F&rft.au=Dekkers%2C+P+E+P&rft.date=2013&rft.issn=2090-4398&rft.volume=2013&rft.spage=205417&rft.epage=205417&rft_id=info:doi/10.1155%2F2013%2F205417&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2090-4398&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2090-4398&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2090-4398&client=summon